Variational Calculation for the Equation of State of Nuclear Matter at Finite Temperatures

An equation of state (EOS) for uniform nuclear matter is constructed at zero and finite temperatures with the variational method starting from the realistic nuclear Hamiltonian composed of the Argonne V18 and UIX potentials. The energy is evaluated in the two-body cluster approximation with the three-body-force contribution treated phenomenologically so as to reproduce the empirical saturation conditions. The obtained energies for symmetric nuclear matter and neutron matter at zero temperature are in fair agreement with those by Akmal, Pandharipande and Ravenhall, and the maximum mass of the neutron star is 2.2 Msolar. At finite temperatures, a variational method by Schmidt and Pandharipande is employed to evaluate the free energy, which is used to derive various thermodynamic quantities of nuclear matter necessary for supernova simulations. The result of this variational method at finite temperatures is found to be self-consistent.Comment: Revised Versio

Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs

BACKGROUND: Radiogenetic therapy is a novel approach in the treatment of cancer, which employs genetic modification to alter the sensitivity of tumor cells to the effect of applied radiation. AIM: To select a potent radiation inducible promoter in the context of brain tumors and to investigate if CArG radio responsive motifs or other elements in the promoter nucleotide sequences can correlate to its response to radiation. METHODS: To select initial candidates for promoter inducible elements, the levels of mRNA expression of six different promoters were assessed using Quantitative RTPCR in D54 MG cells before and after radiation exposure. Recombinant Ad/reporter genes driven by five different promoters; CMV, VEGF, FLT-1, DR5 and survivin were constructed. Glioma cell lines were infected with different multiplicity of infection of the (promoter) Ad or CMV Ad. Cells were then exposed to a range of radiation (0–12 Gy) at single fraction. Fluorescent microscopy, Luc assay and X-gal staining was used to detect the level of expression of related genes. Different glioma cell lines and normal astrocytes were infected with Ad survivin and exposed to radiation. The promoters were analyzed for presence of CArG radio-responsive motifs and CCAAT box consensus using NCBI blast bioinformatics software. RESULTS: Radiotherapy increases the expression of gene expression by 1.25–2.5 fold in different promoters other than survivin after 2 h of radiation. RNA analysis was done and has shown an increase in copy number of tenfold for survivin. Most importantly cells treated with RT and Ad Luc driven by survivin promoter showed a fivefold increase in expression after 2 Gy of radiation in comparison to non-irradiated cells. Presence or absence of CArG motifs did not correlate with promoter response to radiation. Survivin with the best response to radiation had the lowest number of CCAAT box. CONCLUSION: Survivin is a selective potent radiation inducible promoter for glioblastoma viral gene therapy and this response to radiation could be independent of CArG motifs

Near-Infrared Adaptive Optics Spectroscopy of Binary Brown Dwarf HD 130948B and C

We present near-infrared spectroscopy of low-mass companions in a nearby triple system HD 130948 (Gliese 564, HR 5534). Adaptive optics on the Subaru Telescope allowed spectroscopy of the individual components of the 0".13 binary system. Based on a direct comparison with a series of template spectra, we determined the spectral types of HD 130948B and C to be L4 +- 1. If we take the young age of the primary star into account (0.3-0.8 Gyr), HD 130948B and C most likely are a binary brown dwarf system.Comment: 6 pages, 3 figures, accepted for publication in ApJ Letter